MeSH D003231 - conjunctivitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Prednisolone | Prednisolone |  | 1999-05-28 |  |  |
| Prednisolone | Prelone |  | 1986-02-04 |  |  | |
| Taro Pharmaceutical | Prednisolone | Flo-pred | 2028-10-11 | 2008-01-17 |  |  |
| Oxymetazoline | Oxymetazoline |  | 2021-10-04 |  |  | |
| Johnson & Johnson | Oxymetazoline | Visine |  | 1989-03-31 |  |  |
| Sandoz | Prednisolone | Omnipred |  | 1982-01-01 |  |  |
| Genus Lifesciences | Prednisolone, Sulfacetamide | Sulfacetamide Prednisolone |  | 1993-05-27 |  |  |
| Novartis | Prednisolone | Inflamase |  | 1982-01-01 |  |  |
| Prednisolone, Sulfacetamide | Vasocidin |  | 1984-10-05 |  |  |
1
2
3
4
5
6
7
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
0%0/0
Phase 3
54%15/28
Approved: 8Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use